Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Matthew Hellmann"'
Autor:
David G. Coffey, Yuexin Xu, Andrea M. H. Towlerton, Marcin Kowanetz, Priti Hegde, Martine Darwish, Mahesh Yadav, Craig Blanchette, Shannon M. Ruppert, Sarah Bertino, Qikai Xu, Andrew Ferretti, Adam Weinheimer, Matthew Hellmann, Angel Qin, Dafydd Thomas, Edus H. Warren, Nithya Ramnath
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Most patients with advanced non-small cell lung cancer (NSCLC) do not achieve a durable remission after treatment with immune checkpoint inhibitors. Here we report the clinical history of an exceptional responder to radiation and anti-program death-l
Externí odkaz:
https://doaj.org/article/0ad62252e9ae47dfa7add7911dd39d72
Autor:
Jiajia Zhang, Patrick Forde, Taha Merghoub, Julie Brahmer, Matthew Hellmann, Kristen Marrone, Janis Taube, Boyang Zhang, Hongkai Ji, Zhicheng Ji, Justina Caushi, Andrew Pardoll, Kellie Smith, Giacomo Oliveira, Srinivasan Yegnasubramanian, Catherine Wu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/cc00ec0c8b3a4f07bcb201fa39ef9475
Autor:
Enriqueta Felip, Jianda Yuan, Lawrence Fong, Charu Aggarwal, Razvan Cristescu, Myung-Ju Ahn, Alexandra Snyder, Matthew Hellmann, Roy Herbst, Martin Gutierrez, Edward Garon, Jong-Seok Lee, Julie Kobie, Matthew Gubens, Daniel Shao Weng Tan, Joanne WY Chiu, James Chih-Hsin Yang, Giovanna Finocchiaro, Alexander Luft, Gregory Landers, Andrea Basso, Hua Ma, John Palcza
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/f606c751f88546b2b65dd38f5eef52da
Autor:
Matthew Hellmann, Ying Cheng, Toshiaki Takahashi, Gilberto de Castro, M Catherine Pietanza, James Chih-Hsin Yang, Byoung Cho, Rosalyn Juergens, Mustafa Erman, Jessica Bauman, Paul Schwarzenberger, Pingye Zhang
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/2116ff1baf5349cfbe8aac848a2def32
Autor:
Michael Green, Dmitriy Zamarin, Katherine Panageas, Taha Merghoub, Weiping Zou, Cailian Liu, Jedd Wolchok, Matthew Hellmann, Joseph Chan, Hongyu Shi, Hira Rizvi, Jessica Waninger, Aditi Gupta, Nicholas Ceglia, Viola Allaj, Giulia Zago, Nisarg Shah, Sai Sharma, Marissa Mattar, Yonina Bykov, Corrin Wohlhieter, Fathema Uddin, Inna Khodos, Angel Qin, Vinod Balachandran, Sohrab Shah, Andrew McPherson, Jason Lewis, Justin Perry, Elisa de Stanchina, Triparna Sen, John Poirier, Charles Rudin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/40d967b30569450689026463a728aa99
Autor:
Noura J. Choudhury, Jessica A. Lavery, Samantha Brown, Ino de Bruijn, Justin Jee, Thinh Ngoc. Tran, Hira Rizvi, Kathryn C. Arbour, Karissa Whiting, Ronglai Shen, Matthew Hellmann, Philippe L. Bedard, Celeste Yu, Natasha Leighl, Michele LeNoue-Newton, Christine Micheel, Jeremy L. Warner, Michelle S. Ginsberg, Andrew Plodkowski, Jeffrey Girshman, Peter Sawan, Shirin Pillai, Shawn M. Sweeney, Kenneth L. Kehl, Katherine S. Panageas, Nikolaus Schultz, Deb Schrag, Gregory J. Riely
Publikováno v:
Clinical Cancer Research.
Purpose: We describe the clinical and genomic landscape of the non-small cell lung cancer (NSCLC) cohort of the AACR Project GENIE Biopharma Collaborative (BPC). Experimental Design: 1,846 patients with NSCLC whose tumors were sequenced from 2014 to
Autor:
Gregory J. Riely, Marc Ladanyi, Maria Arcila, Ai Ni, Charles M. Rudin, Mark G. Kris, Matthew Hellmann, David B. Solit, Michael Berger, Piro Lito, Francisco Sanchez-Vega, Helena A. Yu, Jordan Dienstag, Hyunjae Ryan Kim, Emmett Jordan, Kathryn C. Arbour
Supplemental Table 1: Tumor Mutational burden according to individual KRAS mutation. Supplemental Table 2: Multivariate Analysis of duration of platinum/pemetrexed chemotherapy in patients with KRAS-mutant NSCLC Supplemental Table 3: Multivariate Ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55819b39163167a40742eec0a8a39d3d
https://doi.org/10.1158/1078-0432.22467000.v1
https://doi.org/10.1158/1078-0432.22467000.v1
Autor:
Gregory J. Riely, Marc Ladanyi, Maria Arcila, Ai Ni, Charles M. Rudin, Mark G. Kris, Matthew Hellmann, David B. Solit, Michael Berger, Piro Lito, Francisco Sanchez-Vega, Helena A. Yu, Jordan Dienstag, Hyunjae Ryan Kim, Emmett Jordan, Kathryn C. Arbour
Purpose: KRAS mutations occur in approximately 25% of patients with non–small cell lung cancer (NSCLC). Despite the uniform presence of KRAS mutations, patients with KRAS-mutant NSCLC can have a heterogeneous clinical course. As the pattern of co-o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::238306537f6e19dd4e70e1a89ff1c151
https://doi.org/10.1158/1078-0432.c.6526506.v1
https://doi.org/10.1158/1078-0432.c.6526506.v1
Autor:
Roy Herbst, Wei-Sen Lam, Matthew Hellmann, Matthew Gubens, Charu Aggarwal, Daniel Shao Weng Tan, Enriqueta Felip, Joanne Chiu, Jong-Seok Lee, James Chih-Hsin Yang, Edward Garon, Giovanna Finocchiaro, Myung-Ju Ahn, Alexander Luft, Gregory Landers, Andrea Basso, Hua Ma, Julie Kobie, John Palcza, Razvan Cristescu, Lawrence Fong, Alexandra Snyder, Jianda Yuan, Martin Gutierrez
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Regular and Young Investigator Award Abstracts.